USPTO serial 79342583
LG CHEM
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jan 9, 2024
- Examiner
- AGREDA, SAMANTHA LEIGH
- Law office
- Historical data usage
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with LG CHEM?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Charles T. J. Weigell
Charles T. J. Weigell Fross Zelnick Lehrman & Zissu, P.C.151 W. 42nd Street, 17th FloorNew York, NY 10036UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Unprocessed polylactic acid (PLA) * artificial * resins; unprocessed acrylonitrile butadiene styrene (ABS) resins; unprocessed polycarbonate (PC) resins; Unprocessed polyvinyl chloride resins; Unprocessed polystyrene resins; unprocessed bioplastics; unprocessed biodegradable plastics; * dendrimer-based * biopolymers for use in the manufacture of [ industrial products, consumer and household products, sealants or packaging ] * capsules for pharmaceuticals * ; [ Bioresins being unprocessed artificial resins; ] * unprocessed bio-polymer resins; unprocessed bio artificial resins; unprocessed bio synthetic resins; * biodegradable polymeric chemicals used in industry; chemical preparations for use in the manufacture of biodegradable resins; Industrial chemicals used in the production and refining of biobased plastics; thermoplastic starch (TPS) for industrial purposes; Unprocessed poly hydroxy alkanoate (PHA) * artificial * resins; Unprocessed poly butylene succinate (PBS) resins; Unprocessed polybuthylene [ adipate-co- ] terephthalate [ (PBAT) ] resins; Unprocessed polyethylene succinate (PES) resins; unprocessed polycaprolactone (PCL) * artificial * resins; unprocessed polyvinyl acetate resins; Unprocessed [ aliphatic ] polyester resins; acetate of cellulose, unprocessed; Unprocessed polyglycolic acid (PGA) * artificial * resins; Unprocessed polyethtylene terephthalate (PET) resins; unprocessed thermoplastic resins; cellulose for industrial purposes | ACTIVE | — |
| 009 | Downloadable multimedia file containing artwork, text, audio, video, games and Internet Web links relating to chemistry, pharmacy and medical science; downloadable image files containing artwork, text, audio, video, games and Internet Web links relating to chemistry, pharmacy and medical science; downloadable computer graphics; raster image processors; downloadable application software for metaverse, namely, for accessing online virtual worlds; metaverse contents operating software being downloadable computer operating software for use in the metaverse; computer interfaces for use in the metaverse; downloadable virtual reality software for teaching and training in the field of chemistry, pharmacy and medical science; downloadable graphical user interface software; virtual reality headsets; downloadable computer software for providing multi-user access to global computer networks; interactive graphics screens being interactive touch screen terminals; downloadable computer application software for implementing the Internet of Things (IoT); downloadable augmented reality software for teaching and training in the field of chemistry, pharmacy and medical science; program for network operating system being downloadable software for operating computer networks; downloadable computer software for use as an electronic wallet; downloadable computer application software for processing commercial transactions using digital assets authenticated by non-fungible tokens (NFTs); downloadable computer application software for authentication of photographs, audio recordings, image files, and video recordings relating to chemistry, pharmacy and medical science using non-fungible tokens (NFTs); downloadable computer application software for blockchain-based platforms, namely, for managing and verifying cryptocurrency transactions using blockchain technology; cloud server being Internet servers; downloadable software for managing digital assets authenticated by Non-Fungible Tokens (NFTs); recorded electronic data files featuring information about digital assets; downloadable image files containing artwork, text, audio, video, games and Internet Web links relating to chemistry, pharmacy and medical science authenticated by non-fungible tokens (NFTs); downloadable image files featuring images of virtual clothing, shoes, bags, hats, glasses, sports goods, artwork, and toys for trading in the metaverse; downloadable image files featuring images of pharmaceuticals, chemicals, and industrial drugs for trading in the metaverse; downloadable image files featuring images of characters for trading in the metaverse; downloadable image files featuring images of user avatars for trading in the metaverse; downloadable computer software for providing information on pharmaceutical products, medicines, and medical devices; downloadable computer software for displaying and accessing medical electronic charts; downloadable computer software for diagnosing diseases for medical purposes; downloadable computer software for use in medical decision support systems, namely, for analyzing medical records and recommending a course of treatment; artificial intelligence (AI) disease analysis software being downloadable artificial intelligence (AI) software for disease data analysis | ACTIVE | — |
| 041 | Arranging and conducting of seminars, conferences and exhibitions for cultural or educational purposes conducted in the metaverse, all in the field of chemistry, pharmacy and medical science; beauty education being instruction in the field of cosmetology, conducted in the metaverse; providing information in the field of education via the metaverse; organization of educational events being seminars, exhibitions, lecture presentations and symposiums in the field of chemistry, pharmacy and medical science via the metaverse; metaverse related experiential learning business, namely, business training via the metaverse; education related to metaverse, namely, instruction in the field of technology relating to virtual worlds; education consulting business related to metaverse, namely, consulting services about education in the field of the metaverse; educational information provision service in the field of metaverse, namely, providing information about education in the field of the metaverse; distance learning services provided on-line, namely, conducting on-line distance learning instruction for expert training for medical personnel, vocational training and employee training, all in the field of chemistry, pharmacy, and medical science; distance learning services, namely, conducting distance learning instruction for expert training for medical personnel, vocational training and employee training, all in the field of chemistry, pharmacy, and medical science; providing distance learning courses in the field of chemistry, pharmacy and medical science; education courses through the internet, namely, providing online educational courses in the field of chemistry, pharmacy and medical science; internet education instruction, namely, providing instruction in the field of digital literacy; publication of periodicals and books in electronic form; instruction and training services, all in the field of chemistry, pharmacy and medical science; vocational education and training services, all in the field of chemistry, pharmacy and medical science | ACTIVE | — |
| 042 | Graphic design of three dimensional displays; development of virtual reality software; constructing an internet platform based blockchain, namely, developing computer platforms using blockchain technology; server hosting of platforms on the Internet for delivery of multimedia content; graphic design; design of information technology systems; cross-platform conversion of digital content into other forms of digital content; metaverse software development; software design and development for blockchain platform; software programming for blockchain platforms; platform as a Service (PAAS) featuring computer software platforms for use in database management; software as a service featuring software for use in database management; programming of software for internet platforms; design and development of computer software; provision of security services for computer networks, computer access and computerized transactions, namely, computer network security consultancy, and monitoring of computer systems for detecting unauthorized access or data breach; mixed reality software development; design and development of metaverse application software; provision of platform as a service (PAAS) featuring computer software platforms for providing information in the medical, health, and pharmaceutical fields; design and development of application software for metaverse for testing and research in the medical, health, and pharmaceutical fields; provision of platform as a service (PAAS) featuring computer software platforms for providing cosmetology information; software development for healthcare-related artificial intelligence services; design and development of application software for use in the metaverse for beauty education and research; testing, analysis, and evaluation of the goods and services of others to determine conformity with certification standards, all provided via the metaverse; testing, analysis, and evaluation of the goods and services of others to determine conformity with certification standards, all provided using digital assets authenticated by non-fungible tokens (NFTs); chemical engineering research services; chemical and petrochemical research; research and development of vaccines and medicines; testing, inspection and research services in the fields of pharmaceuticals, cosmetics and foodstuffs; providing scientific research and development services in the field of environment | ACTIVE | — |
| 044 | Medical consultations; medical clinic services; medical information; providing information in the field of medicine; medical information services provided via the Internet; physical examination services; digital treatment provider on the metaverse in the nature of providing medical treatment services via the metaverse; providing medical information via the metaverse; medical analysis for the diagnosis and treatment of persons; medical analysis services relating to the diagnosis and treatment of patients; medical staff services, namely, nursing services; medical imaging service; medical advisory services relating to medical instruments; medical consultancy relating to pharmaceutical and medical products; medical consultancy and information services relating to pharmaceutical products | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by LG Corp.
- Other trademarks owned by LG Corp.
- Other trademarks owned by LG Corp.
- Other trademarks in Class 001
- Other trademarks in Class 009
- Other trademarks in Class 041
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named LG CHEM
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 8, 2025 | NURC | NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED | — |
| Jun 18, 2025 | LIME | LIMITATION FROM THE IB EXAMINED AND ENTERED | — |
| Jun 18, 2025 | COC. | CORRECTION UNDER SECTION 7 - PROCESSED | — |
| Jun 18, 2025 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Nov 15, 2024 | LIMG | LIMITATION OF GOODS RECEIVED FROM IB | — |
| Apr 29, 2024 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Apr 10, 2024 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Apr 10, 2024 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Apr 9, 2024 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jan 9, 2024 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Jan 9, 2024 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Dec 11, 2023 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Nov 22, 2023 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Nov 22, 2023 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Oct 24, 2023 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Oct 24, 2023 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Oct 24, 2023 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Oct 4, 2023 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Oct 4, 2023 | RFNP | REFUSAL PROCESSED BY IB | — |
| Oct 4, 2023 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Oct 4, 2023 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Sep 18, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 15, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 15, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 15, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 11, 2023 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 11, 2023 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 11, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 25, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 24, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 24, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 22, 2023 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 22, 2023 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 22, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 26, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 25, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 25, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 15, 2023 | RFNT | REFUSAL PROCESSED BY IB | — |
| Dec 27, 2022 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Dec 27, 2022 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Oct 13, 2022 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Oct 12, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 28, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 21, 2022 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jun 17, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 16, 2022 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |